Published in Ann Surg on December 01, 1998
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J Clin Oncol (2010) 1.80
Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg (2000) 1.62
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer (2008) 1.26
Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg (2000) 1.18
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2012) 1.07
Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer (2007) 1.05
Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol (2014) 0.97
Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis (2012) 0.97
The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int (2010) 0.95
Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg (2009) 0.93
Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials. BMC Cancer (2010) 0.89
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52. Clin Colorectal Cancer (2011) 0.89
Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? World J Surg (2009) 0.88
Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model. Ann Surg (2000) 0.83
Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer. World J Surg (2008) 0.83
Evolution in the treatment of metastatic colorectal carcinoma of the liver. World J Gastroenterol (2006) 0.83
Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist. World J Gastroenterol (2014) 0.83
Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials. World J Gastroenterol (2005) 0.82
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. J Surg Oncol (2016) 0.81
Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer. Clin Cancer Res (2008) 0.81
Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastases. Medicine (Baltimore) (2015) 0.81
Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer. J Gastrointest Oncol (2015) 0.81
Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer. Surg Today (2012) 0.80
Strategies for Management of Synchronous Colorectal Metastases. Curr Surg Rep (2014) 0.79
Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg (2003) 0.79
Curative strategies for liver metastases from colorectal cancer: a review. Oncologist (2012) 0.78
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases? Nat Clin Pract Oncol (2008) 0.77
Hepatic artery chemotherapy in the management of colorectal metastases. Proc (Bayl Univ Med Cent) (2002) 0.76
Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience. Colorectal Cancer (2013) 0.75
Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial. PLoS One (2016) 0.75
Impact of adjuvant chemotherapy in patients with curatively resected stage IV colorectal cancer. Medicine (Baltimore) (2015) 0.75
Hemorrhage associated with hepatic artery pseudoaneurysms after regional chemotherapy with floxuridine: case report. Int Semin Surg Oncol (2008) 0.75
Overall survival or other clinical benefits from adjuvant selective intraarterial chemotherapy in patients undergoing curative liver resection for metastatic colorectal tumor. Ann Surg (1999) 0.75
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study. Br J Cancer (2016) 0.75
Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer. Ann Surg Oncol (2017) 0.75
A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases. Int J Colorectal Dis (2015) 0.75
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06
Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35
Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22
Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics (1982) 2.74
Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg (1987) 2.58
Determinants of survival in liver resection for colorectal secondaries. Br J Surg (1986) 2.58
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet (1992) 2.21
Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet (1986) 2.21
Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol (1993) 2.09
Liver resection for metastatic colorectal cancer. Surgery (1986) 1.92
Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery (1993) 1.79
Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg (1989) 1.70
The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery (1969) 1.68
Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg (1985) 1.65
Group sequential procedures: calendar versus information time. Stat Med (1989) 1.57
Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet (1970) 1.48
Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg (1985) 1.46
[Regional adjuvant therapy in colorectal liver metastases: requirements for clinical therapy studies from the statistical viewpoint]. Zentralbl Chir (1995) 1.44
[Resection of liver metastases of colorectal carcinoma: claims and reality]. Dtsch Med Wochenschr (1991) 1.42
Metastatic disease in the liver from colorectal cancer: an appraisal of liver surgery. World J Surg (1982) 1.30
Dormant liver metastases: an experimental study. Br J Surg (1992) 1.28
Vascularization of small liver metastases. Br J Surg (1989) 1.27
Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg (1984) 1.23
Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet (1970) 1.11
Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc (1985) 1.10
A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol (1990) 1.08
Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol (1990) 1.08
Hepatic artery infusion pumps: cannulation techniques and other surgical considerations. Langenbecks Arch Chir (1990) 0.87
Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg (1993) 0.84
[Resection of liver metastases of colorectal tumors. A uni- and multivariate analysis of prognostic factors]. Langenbecks Arch Chir (1996) 0.82
Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases--a pilot study. Eur J Surg Oncol (1987) 0.81
Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer (1987) 0.81
[Pharmacology of regional chemotherapy of colorectal liver metastases]. Zentralbl Chir (1995) 0.81
Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study. Eur J Surg Oncol (1991) 0.80
[Results of resection and adjuvant therapy of liver metastases of primary colorectal tumors--a review of the literature]. Zentralbl Chir (1995) 0.80
Structure of the actin-myosin complex and its implications for muscle contraction. Science (1993) 11.30
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut (2003) 3.91
Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet (1993) 3.45
ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr (2006) 3.36
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol (1999) 2.62
E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res (1993) 2.55
Zinc oxide nanorod based photonic devices: recent progress in growth, light emitting diodes and lasers. Nanotechnology (2009) 2.48
Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest (2000) 2.42
Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer (1996) 2.06
[Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir (1988) 2.02
[Disposable versus reusable instruments in laparoscopic surgery--a controlled study]. Zentralbl Chir (1995) 2.00
Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol (1994) 1.90
Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut (2000) 1.89
Normal modes as refinement parameters for the F-actin model. Biophys J (1995) 1.86
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology (1996) 1.86
A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med (1999) 1.76
De-novo expression of CD44 and survival in gastric cancer. Lancet (1993) 1.75
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol (1997) 1.73
Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol (1995) 1.68
Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment. Cancer Biol Ther (2008) 1.66
Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol (2000) 1.63
Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections. Stat Med (2001) 1.62
Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg (1990) 1.60
Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology (2001) 1.57
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg (1996) 1.50
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50
Nutritional intervention high in vitamins, protein, amino acids, and omega3 fatty acids improves protein metabolism during the hypermetabolic state after thermal injury. Arch Surg (2001) 1.49
Recent advances in FRET: distance determination in protein-DNA complexes. Curr Opin Struct Biol (2001) 1.48
Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int (1996) 1.47
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer. Eur J Surg Oncol (1998) 1.44
Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology (2000) 1.43
Venous complications after orthotopic liver transplantation. Clin Transplant (2000) 1.43
Idiopathic segmental infarction of the greater omentum successfully treated by laparoscopy: report of case. Surg Today (2000) 1.41
Perioperative mucosal pH and splanchnic endotoxin concentration in orthotopic liver transplantation. Br J Anaesth (1996) 1.41
[Continuous intraoperative neuromonitoring of the recurrent laryngeal nerve in thyroid surgery (CIONM) - Where are we now? An update to the European Symposium of Continuous Neuromonitoring in Thyroid Surgery]. Zentralbl Chir (2011) 1.41
Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol (1999) 1.40
[The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI]. Zentralbl Chir (2010) 1.40
[Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder]. Z Gastroenterol (2005) 1.40
[Indirect MR arthrography in the diagnosis of rotator cuff lesions]. Rofo (2000) 1.39
[Ventilation in prone position in a 5-year-old child after multiple trauma. Effective treatment of persistent atelectasis]. Unfallchirurg (2000) 1.39
[Carcinoid tumor of the stomach--aspects of surgical therapy]. Chirurg (1991) 1.39
[Post-aggression metabolism: attempt at a status determination]. Infusionsther Transfusionsmed (1994) 1.39
[Repair procedures in surgery of inguinal hernia in their historical evolution]. Zentralbl Chir (1993) 1.39
[Elective colon resection in Germany. A survey of the perioperative anesthesiological management]. Anaesthesist (2007) 1.39
[Gardner syndrome and thyroid gland carcinoma]. Langenbecks Arch Chir (1997) 1.39
Donor criteria in hepatic transplantation. Langenbecks Arch Chir (1994) 1.38
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
Antireflux surgery in children suffering from reflux-associated respiratory diseases. Pediatr Pulmonol (1999) 1.38
Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst (1999) 1.36
Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med (1995) 1.30
A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res (2001) 1.29
Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol (2000) 1.28
In vitro edible muscle protein production system (MPPS): stage 1, fish. Acta Astronaut (2002) 1.26
X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol (2013) 1.26
99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun (1989) 1.25
Historical evolution of inguinal hernia repair. World J Surg (1997) 1.25
INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene (2001) 1.23
Load-bearing characteristics of lumbar facets in normal and surgically altered spinal segments. Spine (Phila Pa 1976) (1983) 1.23
Pyogenic infections of the pubic symphysis. Ann Intern Med (1982) 1.22
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules. Exp Clin Endocrinol Diabetes (2009) 1.21
Regression of nonresectable inflammatory myofibroblastic tumours after treatment with nonsteroidal anti-inflammatory drugs. Eur J Clin Invest (2004) 1.19
Experiences with percutaneous endoscopic gastrostomy. World J Surg (1996) 1.19
Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth (2004) 1.18
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg (1994) 1.15
Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med (2001) 1.15
Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. Eur J Surg Oncol (2007) 1.14
Occurrence of second tumors in man after anticancer drug treatment. Cancer Treat Rev (1982) 1.13
[Entero-enteral invagination of the small intestine in adults. A rare cause of "uncertain abdomen"]. Langenbecks Arch Chir (1993) 1.13
Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology (1992) 1.13
Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer (2009) 1.11
Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery (1998) 1.11
Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract (2008) 1.11
Differential regulation of hepatic glutathione transferase and glutathione peroxidase activities in the rat. Biochem Pharmacol (1985) 1.11
Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes). Arch Pathol Lab Med (2000) 1.10
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. Transplant Proc (1999) 1.09
Suppression of the emotional Stroop effect by increased anxiety in patients with social phobia. Behav Res Ther (1997) 1.09
Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer (2011) 1.09
[Therapy of primary hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.08
Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer (2000) 1.07
Preoperative risk assessment of hepatic resection for malignant disease. World J Surg (1997) 1.06
[Diagnostic imaging of hepatocellular carcinoma]. Dtsch Med Wochenschr (1997) 1.06
Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Dig Dis Sci (2000) 1.05